ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA OR CHRONIC MYELOID-LEUKEMIA IN THE 5TH DECADE OF LIFE

被引：13

作者：

BEELEN, DW

QUABECK, K

MAHMOUD, HK

SCHAEFER, UW

BECHER, R

SCHMIDT, CG

BAMBERG, M

QUAST, U

GROSSEWILDE, H

HARALAMBIE, E

LINZENMEIER, G

STOLLMANN, B

RICHTER, HJ

HANTSCHKE, D

THRAENHARDT, O

HENNEBERGQUESTER, KB

LUBOLDT, W

机构：

[1] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT RADIOTHERAPY, D-4300 ESSEN 1, FED REP GER

[2] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT IMMUNOGENET, D-4300 ESSEN 1, FED REP GER

[3] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT MICROBIOL, D-4300 ESSEN 1, FED REP GER

[4] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT PEDIAT, D-4300 ESSEN 1, FED REP GER

[5] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT PATHOL, D-4300 ESSEN 1, FED REP GER

[6] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT DERMATOL, D-4300 ESSEN 1, FED REP GER

[7] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT VIROL & IMMUNOL, D-4300 ESSEN 1, FED REP GER

[8] UNIV ESSEN GESAMTHSCH, W GERMAN TUMOR CTR, DEPT TRANSFUS MED, D-4300 ESSEN 1, FED REP GER

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 11期

关键词：

D O I：

10.1016/0277-5379(87)90447-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1665 / 1671

页数：7

共 18 条

[1] BONE-MARROW TRANSPLANTATION OR CHEMOTHERAPY AFTER REMISSION INDUCTION FOR ADULTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA - A PROSPECTIVE COMPARISON [J].

APPELBAUM, FR ;

DAHLBERG, S ;

THOMAS, ED ;

BUCKNER, CD ;

CHEEVER, MA ;

CLIFT, RA ;

CROWLEY, J ;

DEEG, HJ ;

FEFER, A ;

GREENBERG, PD ;

KADIN, M ;

SMITH, W ;

STEWART, P ;

SULLIVAN, K ;

STORB, R ;

WEIDEN, P .

ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) :581-588

[2] INFLUENCE OF UNDERLYING DISEASE AND DONOR SEX ON THE INCIDENCE OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

BEELEN, DW ;

QUABECK, K ;

MAHMOUD, HK ;

GROSSEWILDE, H ;

SCHAEFER, UW ;

SCHMIDT, CG .

BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (03) :385-386

[3] BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES IN PATIENTS AGED 30 YEARS OR OLDER [J].

BLUME, KG ;

FORMAN, SJ ;

NADEMANEE, AP ;

ODONNELL, MR ;

SNYDER, DS ;

FAHEY, JL ;

SNIECINSKI, IJ ;

FINDLEY, DO ;

LIPSETT, JA ;

ZAIA, JA ;

METTER, GE ;

HILL, LR .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1489-1492

[4]

BROSS DS, 1984, BLOOD, V63, P1265

[5] CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].

GLUCKSBERG, H ;

STORB, R ;

FEFER, A ;

BUCKNER, CD ;

NEIMAN, PE ;

CLIFT, RA ;

LERNER, KG ;

THOMAS, ED .

TRANSPLANTATION, 1974, 18 (04) :295-304

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[7]

KLINGEMANN HG, 1986, BLOOD, V67, P770

[8] BONE-MARROW TRANSPLANTATION FOR CHRONIC GRANULOCYTIC-LEUKEMIA [J].

MAHMOUD, HK ;

SCHAEFER, UW ;

SCHUNING, F ;

BEELEN, D ;

BECHER, R ;

SCHMIDT, CG ;

ALBERTI, W ;

HARALAMBIE, E ;

LINZENMEIER, G ;

STOLLMANN, B ;

GROSSEWILDE, H ;

RICHTER, HJ ;

HANTSCHKE, D ;

LUBOLDT, W .

KLINISCHE WOCHENSCHRIFT, 1985, 63 (12) :560-564

[9]

MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

[10]

MOLLS M, 1987, STRAHLENTHER ONKOL, V163, P237

← 1 2 →